Clinical and pharmacological group: & nbsp

Other synthetic antibacterial agents

Included in the formulation
  • Atrikan 250
    capsules inwards 
  • АТХ:

    P.01.A.X.08   Tenonitrosol

    Pharmacodynamics:

    The derivative of nitro-5-imidazole, possesses trichomonadocidal and fungistatic action. It recovers 5-nitro group due to transport proteins of anaerobic bacteria and protozoan microorganisms. The restored 5-nitro group of tenonitrosol inhibits the synthesis of nucleic acids of DNA from microorganism cells, which leads to their death.

    Active at respect Trichomonas vaginalis and Candida albicans.

    Pharmacokinetics:

    After oral administration, it is completely absorbed in the gastrointestinal tract. The maximum concentration in the blood plasma is achieved in 2-3 hours. The connection with plasma proteins is 20%.

    The therapeutic effect develops 1-3 hours after the beginning of the admission. Metabolism in the liver.

    The half-life is 5-6 hours. Elimination by the kidneys. Removed during hemodialysis.

    Indications:

    It is used to treat infectious and inflammatory diseases of the urogenital system: trichomoniasis, candidiasis.

    I.A50-A64.A59   Trichomoniasis

    I.B35-B49.B37   Candidiasis

    Contraindications:

    Acute and chronic hepatic insufficiency, individual intolerance, children under 18 years of age.

    Carefully:

    Hypersensitivity.

    Pregnancy and lactation:

    Recommendations for FDA - Category C. It is used with caution during pregnancy and lactation in cases where the intended benefit exceeds the risk to the fetus and newborn.

    Dosing and Administration:

    Inside at meal time, 250 mg in the morning and in the evening for 4 days.

    The highest daily dose: 500 mg.

    The highest single dose: 250 mg.

    Side effects:

    central nervous system: headache, dizziness.

    Hematopoietic system: leukocytosis or leukopenia.

    Digestive system: nausea, a sense of metallic taste in the mouth, a decrease in appetite, constipation or diarrhea.

    urinary system: staining of urine in red-brown color due to the metabolite of 2-oxytenonitrosol.

    Local Reactions: itching, burning, irritation of the mucous membrane of the vagina.

    Allergic reactions.

    Overdose:

    Vomiting, diarrhea, ataxia, paresthesia, convulsions.

    Treatment is symptomatic. Effective hemodialysis.

    Interaction:

    With the simultaneous use of alcohol, disulfiramoid reactions develop: skin hyperemia, vomiting, cramping pains in the lower abdomen.

    Strengthens the effect of indirect coagulants.

    Incompatible with nondepolarizing muscle relaxants (vecuronium bromide).

    With simultaneous application accelerate elimination and reduce the concentration of tenonitrosol in blood plasma drugs that stimulate enzymes of microsomal oxidation in the liver (phenytoin, phenobarbital).

    Enhances the toxic effects of lithium preparations.

    With simultaneous use with cimetidine, the concentration of tenonitrosol in the blood serum increases, which leads to an increase in side effects.

    Special instructions:

    When treating Trichomonas and Candida colpitis, women need treatment for sexual partners and abstinence from sexual activity for the period of taking the drug.

    Instructions
    Up